Kalorama Information: $407 Million Market for MicroRNA Tools and Services

News provided by

May 18, 2016, 10:02 ET

NEW YORK, May 18, 2016 /PRNewswire/ -- The global market for microRNA (miRNA) tools and services had estimated revenues of $407 million in 2015, according to Kalorama Information. The global miRNA market continues to exhibit a trend of solid growth, given the growing interest from researchers in various areas in understanding the function and biological role of miRNA. Furthermore, researchers are increasingly looking to identify and develop miRNA-based biomarkers and therapeutics for a variety of diseases, such as cancer, cardiovascular, infectious, and neurodegenerative disorders. The healthcare market researcher's report, MicroRNA Tools and Services Market, examines the overall market for miRNA analysis.

MicroRNA Tools and Services Market can be found at Kalorama Information: http://www.kaloramainformation.com/redirect.asp?progid=88704&productid=10044134.

MicroRNAs are a class of small, non-coding RNA molecules involved in the regulation of gene expression. The function of miRNAs is determined to a large extent by their expression levels. Currently, three major technologies are employed for profiling the expression of miRNA in various biological samples: amplification-based (real-time, quantitative reverse transcription polymerase chain reaction – qRT-PCR), hybridization-based (planar microarrays and bead-based arrays), and sequencing-based (next-generation sequencing) technologies. miRNAs have been detected in many types of tissues, as well as extracellularly in biofluids such as serum, plasma, saliva and urine. miRNAs are highly stable in samples such as formalin-fixed, paraffin-embedded (FFPE) tissue, plasma and serum, rendering them particularly useful for the development of biomarkers and clinical diagnostics.

The overall market for miRNA analysis tools and services is a dynamic market driven by constant innovation and translation of scientific knowledge to clinical applications. Numerous life sciences instrumentation and reagent companies participate in this market with different capabilities, developing and commercializing a large variety of products.

A number of companies, from small biotechs to big pharmaceutical firms, are committed to miRNA diagnostics. The technology is innovative, and offers the promise of non-invasive diagnostics for cancer, diabetes and other disorders that could be cheaper, faster, and more accurate than existing tests. Because of the significance of microRNA in the regulation of post-transcriptional gene expression, there is great interest in diagnostics that would serve as early warning indicators of malignancy. It is possible that – with five to ten years of investigation – this technology could revolutionize the diagnosis and treatment of cancer and a number of other pressing health concerns.

MicroRNA Tools and Services Market provides market information for the major technologies, including global revenues and forecast for the qRT-PCR segment of the miRNA analysis tools market, 2013-2016 and 2020; global revenues and forecast for the hybridization-based segment of the miRNA analysis tools market, 2013-2016 and 2020; global revenues and forecast for the NGS segment of the miRNA analysis tools market, 2013-2016 and 2020; and global revenues and forecast for the functional tools segment of the miRNA analysis tools market, 2013-2016 and 2020. Further, the report discusses the applications of miRNA and profiles leading companies in the market, including Thermo Fisher Scientific, Exiqon, Dharmacon, Qiagen, and Illumina.

MicroRNA Tools and Services Market can be found at Kalorama Information: http://www.kaloramainformation.com/redirect.asp?progid=88704&productid=10044134.

About Kalorama Information

Kalorama Information, a division of MarketResearch.com, supplies the latest in independent medical market research in diagnostics, biotech, pharmaceuticals, medical devices and healthcare; as well as a full range of custom research services. Reports can be purchased through Kalorama's and are also available on www.marketresearch.com and www.profound.com.

We routinely assist the media with healthcare topics. Follow us on Twitter, LinkedIn and our blog at www.kaloramainformation.com.

Contact:
Bruce Carlson
(212) 807-2622
[email protected]

Logo - http://photos.prnewswire.com/prnh/20150831/262422LOGO

SOURCE Kalorama Information